SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,525.67 -61.07
(-0.13%)

Dow Jones

6,603.69 7.37
(0.11%)

Hang Seng

53,162.49 699.22
(1.33%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.02 -0.15
(-0.16%)

EUR-INR

107.32 -0.65
(-0.60%)

GBP-INR

123.03 -0.78
(-0.63%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506879

INE942C01045

24.267589

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUJTHEM

57.29

2740.48

EPS(TTM)

Face Value()

Div & Yield %

4.39

0.27

Back

Syngene International consolidated net profit declines 36.76% in the September 2025 quarter

Nov 06,2025

Net profit of Syngene International declined 36.76% to Rs 67.10 crore in the quarter ended September 2025 as against Rs 106.10 crore during the previous quarter ended September 2024. Sales rose 2.20% to Rs 910.60 crore in the quarter ended September 2025 as against Rs 891.00 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	910.60	891.00	2
OPM %	21.91	27.47	-
PBDT	201.70	248.20	-19
PBT	85.20	137.30	-38
NP	67.10	106.10	-37

73,319.55 185.23 ( 0.25%)

46,525.67 -61.07 (-0.13%)

6,603.69 7.37 (0.11%)

53,162.49 699.22 (1.33%)

10,436.29 71.50 (0.69%)

93.02 -0.15 (-0.16%)

107.32 -0.65 (-0.60%)

123.03 -0.78 (-0.63%)

0.58 0.00 (-0.67%)